Gershwin, M. Eric

Publishing since 1987 (Dinosaur)

Has published 326 publications in 24 years

Number of publications published per year by Gershwin, M. Eric. (Source : PubMed)

Distribution of publications types for Gershwin, M. Eric. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Youinou P, Pers JO, Gershwin ME, Shoenfeld Y. Geo-epidemiology and autoimmunity. J. Autoimmun. 2010;34;3
Borchers AT, Naguwa SM, Keen CL, Gershwin ME. The implications of autoimmunity and pregnancy. J. Autoimmun. 2010;34;3
Chang C, Gershwin ME. Drugs and autoimmunity--a contemporary review and mechanistic approach. J. Autoimmun. 2010;34;3
Invernizzi P, Selmi C, Gershwin ME. Update on primary biliary cirrhosis. Dig Liver Dis 2010
Ueno Y, Ambrosini YM, Moritoki Y, Ridgway WM, Gershwin ME. Murine models of autoimmune cholangitis. Curr. Opin. Gastroenterol. 2010
Feng W, Cui Y, Zhan H, Shi M, Cui W, Guo K, Li Q, Song C, Zhang Y, Mori T, Gershwin ME, Abraham NG, Ikehara S. Prevention of premature ovarian failure and osteoporosis induced by irradiation using allogeneic ovarian/bone marrow transplantation. Transplantation 2010;89;4
Shimoda S, Harada K, Niiro H, Taketomi A, Maehara Y, Tsuneyama K, Kikuchi K, Nakanuma Y, Mackay IR, Gershwin ME, Akashi K. CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis. Hepatology 2010;51;2 $Link to CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis.$
Agmon-Levin N, Shapira Y, Selmi C, Barzilai O, Ram M, Szyper-Kravitz M, Sella S, Katz BS, Youinou P, Renaudineau Y, Larida B, Invernizzi P, Gershwin ME, Shoenfeld Y. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J. Autoimmun. 2010;34;1
Selmi C, Torok NJ, Affronti A, Gershwin ME. Genomic variants associated with primary biliary cirrhosis. Genome medicine 2010;2;1
Moritoki Y, Lian ZX, Lindor K, Tuscano J, Tsuneyama K, Zhang W, Ueno Y, Dunn R, Kehry M, Coppel RL, Mackay IR, Gershwin ME. B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice. Hepatology 2009;50;6

[ See timeline ] [ See all publications ]

h=59

means that Gershwin, M. Eric has 59 papers cited a least 59 times - methodology

Key figures

326 pub in 24 years
13.6 publications/year
best year 2009 with 35 pub
h-index 59 with 326 pub
h-ratio : 18 %

See Timeline

Ranking

It's me !

Click here if you are
Gershwin, M. Eric.

Most frequent Journals

Hepatology (60x)
J. Autoimmun. (59x)
J. Immunol. (34x)
Ann. N. Y. Acad. Sci. (14x)
Gastroenterology (14x)

Main affiliation

Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, 451 Health Sciences Drive, Suite 6510, Davis, CA 95616, USA.

Latest co-workers

Agmon-Levin N Ansari AA Borchers AT Coppel RL Invernizzi P Keen CL Kikuchi K Lian ZX Mackay IR Moritoki Y Naguwa SM Podda M Selmi C Shimoda S Shoenfeld Y Tsuneyama K Ueno Y Yang GX Youinou P Zhang W

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.